Skip to main content

Role of ambulatory blood pressure monitoring in elderly hypertensive patients



Arterial hypertension is facing some changes in the last years. Its prevalence is increasing in elderly subjects. This growing prevalence is due to longer survival of the population worldwide, among other factors. On the other hand, recent guidelines have insisted in the relevance of out of office blood pressure measurements, to improve diagnostic and management of hypertension. Therefore, elderly subjects with hypertension could benefit from out of office blood pressure measurements, like ambulatory blood pressure measurements; nevertheless, there are very few or no specific recommendations regarding this.


In this review, we will gather the most important information about this subject.


As hypertension in the elderly has some specific characteristics related to aging of the cardiovascular system, the most important aspect could be that these characteristics make ambulatory blood pressure measurement suitable for its use in elderly. Among those a higher prevalence of white coat hypertension, white coat phenomenon, and a higher nocturnal blood pressure and higher prevalence of nondipper and riser pattern, represent aspects that should be considered for better diagnostic and an improved management.


As the prevalence of hypertension will grow in the next years, more studies specifically directed to this subject are needed.


Arterial hypertension is the principal risk factor for cardiovascular disease (CVD) and affects a portion of the population equivalent to 22.3% globally and 26.5% in middle income countries [1]. Hypertension is a global pandemic that is growing fast. In 2010, some estimates suggested that one in three of adults, worldwide, had hypertension [2]. This prevalence is growing; throughout the last years, the number of adults with raised blood pressure increased from 594 million in 1975 to 1,13 billion in 2015 [3]. In Korea, recent data show, that in females the estimated number of people with hypertension is 1.96 million for men and 2.99 million for women among the population aged 65 or older [4]. This increase is due to different factors, one of them being longer survival of the population worldwide, making hypertension more prevalent in older adults [5].

Another important aspect related to hypertension is that all recent guidelines have highlighted the relevance of out of office blood pressure (BP) measurements in diagnosis, evaluation, and management of hypertension, mainly ambulatory BP measurement (ABPM) and home blood pressure measurement [6,7,8,9,10,11,12,13]. This is mainly due to some aspects of ABPM, which make it, more suitable than office BP measurement (OBPM) for diagnosis and management. In summary ABPM gives a larger number of readings than OBPM, provides a profile of BP behavior in the patient’s usual daily environment, allows identification of white coat hypertension phenomena (defined as refers to the condition in which BP is elevated in the office, but is normal when measured by ABPM, HBPM, or bot h[8])and masked hypertension phenomena (defined as refers to the condition in which in whom the BP is normal in the office, but is elevated when measured by HBPM or ABP M[8]), demonstrates nocturnal hypertension (defined as Night-time (or asleep) mean SBP > _120 and/or mean DBP > _70 [8]), assesses dipping pattern (defining dipper if their nocturnal BP falls by > 10% of the daytime average BP value [8]), and BP variability over the 24-h period, assesses the 24-h efficacy of antihypertensive medication, and is a stronger predictor of cardiovascular morbidity and mortality than OBPM [6]. Therefore, in this narrative review we aimed to search for recommendations advantages and particularities of ABPM in elderly patients.

Current recommendations for ABPM in elderly

But what do clinical guidelines, and position papers, recommend on ABPM in elderly subjects? There is no specific guideline for this subject. In fact, the 2021 European Society of Hypertension practice guidelines for office and out of office BP measurement [14] define the clinical indications for ABPM with no specific reference to elderly. Nevertheless, the previous European Society of Hypertension Position Paper on ABPM, published in 2013 [6] includes assessing hypertension in the elderly in the clinical indications for ABPM, since some major age-related changes could only be ascertained through ABPM [15, 16]:

  • White coat hypertension (WCH): That is more common in older than in younger adults.

  • Pulse pressure: As there is a predominant increase in 24-h systolic BP with a mild decrease in 24-h diastolic BP after 60–70 years of age, as a result, an increase in 24-h pulse pressure occurs and, therefore, the prevalence of 24-h isolated systolic hypertension is higher.

  • Nondipping pattern is more common in the elderly.

  • Exaggerated BP variability and morning BP surge is also more common in elderly subjects.

  • Postural and postprandial hypotension is also more common.

Other guidelines point out that out of office BP, preferably ABPM, in addition to an accurate, standardized OBPM, should be undertaken to exclude white coat effect [12, 13].

These changes are, often, indicative of autonomic failure, therefore it is important to identify them, so that treatment can be tailored to take account of such fluctuations in BP. They are, also, relevant as outcome studies in the elderly have shown that 24-h systolic BP, as 24-h ambulatory pulse pressure are more closely associated with cardiovascular events, cardiovascular mortality, and total mortality than office BP, being these associations closer for stroke than coronary artery disease [15,16,17,18,19,20].

More specifically, the Spanish ABPM Guidelines recommend ABPM in elderly patients since this population group has specific characteristics that requires an ABPM to confirm, such as a higher prevalence of WCH, an alteration of the circadian profile with a higher proportion of the reduced dipping profile and a higher prevalence of postprandial and orthostatic hypotension (OH). All these alterations are associated with increased cardiovascular risk and mortality. Poor sleep quality in the elderly can affect the interpretation of ABPM results [21].

Specifical characteristics of hypertension in the elderly in which ABPM could be helpful

Hypertension in elderly subjects is a special situation due to different aspects. We know that the prevalence of hypertension rises with age, particularly, in Korea among hypertensive patients, the proportion of hypertensive patients aged 65 years or older was 37.4% in 2018 [14]. A recent systematic review, including 135 population-based studies of near a million adults from 90 countries found that, in adults aged ≥70 years, the estimated prevalence of hypertension was 73.6% for men and 77.5% for women in high income countries and 65.6% for men and 74.7% for women in low- and middle-income countries [5].

Beside the increasing prevalence [22], there are other characteristics of hypertension in elderly subjects. As for the phenotype of hypertension in the elderly some differential characteristics have been established.

Isolated systolic hypertension

Cross-sectional and longitudinal population studies have shown that systolic BP continuously increases with age, while diastolic BP rises until 50 years of age and then levels off or even slightly decreases [23]. This phenomenon, together with the arterial stiffening occurring in all great arteries, explains why the prevalence of isolated systolic hypertension rises with age and becomes the predominant type of hypertension in both treated and untreated elderly subjects, a highly significant problem in elder subjects. These changes cause an increase in pulse pressure which is known as a risk factor for clinical and subclinical cardiovascular disease [24, 25]. Besides that, some data point out that a lower diastolic BP could cause greater morality in older hypertensive patients [25].

White coat hypertension

It is also called isolated office hypertension, and it is referred to those patients that present a persistent BP elevation in the office with a normal BP outside of the office. This phenomenon is more prevalent in older subjects, and advancing age is the strong determinant of WCH [26]. In the hypertension in the very elderly trial (HYVET), white coat effect, defined as clinic BP minus daytime ambulatory BP, were about 40 mmHg and 20 mmHg in systolic BPs at baseline and follow-up, respectively [27].

Nocturnal hypertension and nondipping pattern

In older hypertensive patients, one of the age-associated BP abnormalities could be the loss of nocturnal BP dip, therefore, the proportion of nondippers tends to increase compared with that of in younger subjects [26]; in some studies, up to 43% of elderly hypertensive patients could have a nocturnal BP elevation [28], this is even more frequent in elderly frail subjects [29]. These changes in circadian pattern, among elderly hypertensive patients, are associated with an increased cardiovascular risk. So, uncontrolled nocturnal hypertension is a predictor of future cardiovascular events [30]. Nevertheless, other studies have found some differences between treated and untreated elderly patients, in reference to high CV risk pattern. So, in elderly hypertensive treated patient, the extreme dipper is associated to a high morning surge, followed by the reverse dippers, nondippers, and dippers with a high morning surge. But, in general elderly population, the highest risk pattern was observed among the reverse dippers, followed by the nondippers, extreme dippers with a high morning surge, and dippers with a high morning surge [31].

However, we should not forget that quality of sleep-in elderly patients can be affected by concomitant conditions, such as prostatic hypertrophy, sleep apnoea, and sleep fragmentation, and in such cases, nocturnal BP loses some of its prognostic significance [5].

Orthostatic hypotension

This type of BP dysregulation could be very frequent in elderly. In community dwelling, Asian subjects, the prevalence of OH was found to be an 11.0% [32]. However, in a recent meta-analysis, a 35.2% of geriatric outpatients had OH [33]. Moreover, one recent post-hoc analysis of a subpopulation in the SPRINT trial examined the association of OH with WCH and systolic BP night reduction. Those with OH, had higher prevalence of WCH (15% vs. 7% without OH) and OH was significantly associated (odds ratio [OR], 2.24; 95% confidence interval [CI], 1.28–4.27). Those with OH also have a higher prevalence of nondipping pattern (25% vs. 14% without OH) being significantly associated to reverse dipping (OR, 2.29; 95% CI, 1.31–3.99) [34].

Vallelonga et al. have found that some selected ABPM parameters (number of hypotensive episodes and the presence of awakening hypotension), may be used to screen patients for OH [35].

Other aspects related to ABPM in elderly

Beside these phenotypic characteristics of hypertension in elderly subjects, this population presents some other relevant problems. One of them is that the available evidence on the efficacy and safety of BP lowering treatment in these patients is scarce [36].


Another important question to be considered is the possibility of an association between hypertension and frailty syndrome in older patients. This possibility is far from clear for various reasons as, for example, the different definitions and tools used to measure of frailty in the available studies, that are, by the way, very few and with low number of subjects included.

As for the influence of frailty on the 24-h BP pattern, it has been explored in a short study with population above 80 years. In this study, frail patients had higher nocturnal systolic BP, and were independently associated with higher risk of nondipping and reduced nighttime systolic BP fall [29].

In another retrospective study, Zhu et al. [37] included elderly patients with essential hypertension who underwent ABPM, assessing frailty by a Rockwood’s frailty index. A greater blood systolic BP variability (particularly average real variability [ARV] and coefficient of Variability) were independently associated with higher frailty status.

Cognitive decline

Cognitive decline is increasing its prevalence and it is known that a well-designed management of hypertension, starting on middle age may reduce the onset of dementia in the elderly [38].

Kim et al. [39] in a recent paper investigated whether higher BP variability (BPV) is associated with faster declines in cognitive function in 1240 Korean ischemic stroke patients, belonging to the PICASSO trial. After adjusting for multiple variables, higher BPV was independently associated with faster cognitive decline over time, measured by Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment, with no significant intergroup difference in cognitive changes associated with mean systolic BP.

Another Chinese study was aimed at identifying the relevance of ABPM in cognitive disfunction assessed through MMSE and magnetic resonance imaging [40]. They found that those with cognitive impairment in MMSE had significantly higher nighttime systolic BP and more nocturnal BP rise compared to the non-cognitive impairment group. As for the magnetic resonance angiography (MRI) results nocturnal BP rise was significantly associated with greater white matter hyperintensities (WMHs).

Hypertension mediated target organ damage

There is, at least, one study which tried to investigate the relationship between systolic Blood pressure variabily [SBPV] and hypertension mediated target organ damage in elderly patients with hypertension. They found the incidences of coronary heart disease and atherosclerotic plaque as well asintima media Thickness (IMT), left ventricular mass Index (LVMI), and microalbuminuria (MA) were higher in the high BPV group than those in the low BPV group (P < 0.05 or P < 0.01). The multivariate results showed that 24-h SBPV was associated with IMT, LVMI, and MA [41].

Heart failure

With increasing age of the population, a high proportion of elderly hypertensives become HF patients, but still prospective studies are required to further investigate the optimal blood pressure target for patients with heart failure [42].

As for heart failure (HF), in the Japan ABPM prospective study, 6359 patients (68.6 ± 11.7 years of age, 48% male patients) with at least one cardiovascular risk factor, without cardiovascular disease underwent ABPM at baseline, and were followed annually for possible atherosclerotic cardiovascular disease and HF. The authors found that nighttime BP levels and a riser pattern were independently associated with the total cardiovascular event rate, for HF [43].

Three studies were aimed to evaluate whether ABPM can identify elderly subjects with HF with a worse prognosis. The University of Nara HF study was aimed to assess if they were any association between outcome of elderly patients with different types of HF and BP measured by ABPM. Nocturnal hypertension and nondipper pattern were not associated with either all-cause or cardiovascular mortality in patients with HF with reduced ejection fraction (HFrEF), HF with mid-range EF (HFmrEF), or HF with preserved EF (HFpEF), except for sleep-time systolic BP in HFrEF. However, the riser pattern was a significant and independent predictor of all-cause and cardiovascular deaths in patients with HFpEF [44].

Komori et al. [43] tested if riser BP pattern is associated with adverse outcomes in HFpEF. And found that those with riser BP pattern subgroup had a significantly higher incidence of the composite outcome than the other subgroups of HFpEF patients [45]. Our group has shown, that in older patients with chronic HF (76.3% with HFpEF), a nondipper or riser BP pattern measured by ABPM was associated with a higher risk of hospitalization and death due to HF [46].

Finally, the ambulatory BP in HFpEF Outcomes Global Registry (HFPEF Global, NCT04065620) is an ongoing observational cohort study that has been designed to assess the association ABPM with cardiovascular outcomes in HFpEF, taking also into considerations confounders such as comorbidities, frailty, and functional capacity [47].

Cerebrovascular disease

About cerebrovascular disease in the elderly, the INFINITY trial tried to elucidate the effects of intensive versus standard lowering of BP on ABPM, (measured by 24-h average systolic BP) on mobility, white matter disease progression, and cognitive function after 3 years in elderly hypertensives (age ≥ 75 years) with MRI evidence of WMH lesions. Intensive lowering did not result in differences in mobility outcomes but was associated with a reduction in accrual of subcortical white matter disease [48].

In the Oxford Vascular Study, the association between beat-to-beat BPV and cardiovascular events in elderly patients, 6 weeks after a transient ischemic attack or nondisabling stroke was assessed. Beat-to-beat BPV predicted recurrent stroke and cardiovascular events, independently of mean systolic BP and risk factors [49].

Intensive BP control for the elderly

As shown in SPRINT and HYVET, achieved daytime systolic BP of about 126 mmHg was tolerable to the elderly patient during intensive BP control. Because BP measurement in the clinic, measured by automated office blood pressure measurement [AOBPM], and conventional clinic BP can be differed, according to the reference daytime BPs measured by ABPM, masked uncontrolled hypertension or white coat uncontrolled hypertension could be found [50]. In the setting when home BP was not consistent or borderline, ABPM could provide the most accurate achieved BPs during intensive BP control.


Hypertension management in elderly hypertensive subjects should include a comprehensive evaluation, to detect also comprehensively their cardiovascular risk. Such an evaluation will help us to know whether a BP lowering strategy, could result in a net benefit, for older patients, and do not increase the safety risks, which are associated to these strategies. Those include OH, WCH, falls, and polypharmacy. This evaluation could also include other parameters related to ABPM, as BP variability, nocturnal hypertension or dipper pattern, which have been associated to higher CV risk. Therefore, ABPM could be a useful tool that could answer many of these questions, and to improve hypertension management in older patients. More specific studies investigating the relevance of ABPM in elderly subjects are needed.

Availability of data and materials

All data generated or analyzed during this study are included in this published article. For other data, these may be requested through the corresponding author.



Ambulatory blood pressure measurement


Automated office blood pressure measurement


Average real variability


Blood pressure


Blood pressure variability




Cardiovascular disease


Ejection Fraction


Home blood pressure measurement


Heart failure


Heart failure with mid-range EF


Heart failure with preserved EF


Heart failure with reduced EF


Hypertension in the very elderly trial


Intima Media Thickness


Left Ventricular Mass Index




Magnetic resonance angiography


Mini-Mental State Examination


Office blood pressure measurement


Orthostatic hypotension


White coat hypertension


White matter hyperintensities


  1. Camafort M, Alcocer L, Coca A, Lopez-Lopez JP, López-Jaramillo P, Ponte-Negretti CI, et al. Latin-American ambulatory blood pressure registry (MAPA-LATAM): an urgent need. Rev Clin Esp (Barc). 2021;221:547–52.

    Article  CAS  Google Scholar 

  2. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16:223–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet. 2017;389:37–55.

    Article  Google Scholar 

  4. Kim HC, Lee H, Lee HH, Seo E, Kim E, Han J, et al. Korea hypertension fact sheet 2021: analysis of nationwide population-based data with special focus on hypertension in women. Clin Hypertens. 2022;28(1):1.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Camafort M, Kario K. Hypertension, heart failure, and frailty in older people: a common but unclear situation. J Clin Hypertens (Greenwich). 2020;22:1763–8.

    Article  Google Scholar 

  6. O’Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31:1731–68.

    Article  PubMed  Google Scholar 

  7. Lee HY, Shin J, Kim GH, Park S, Ihm SH, Kim HC, et al. 2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension. Clin Hypertens. 2019;25:20.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–104.

    Article  PubMed  Google Scholar 

  9. Barroso WK, Rodrigues CI, Bortolotto LA, Mota-Gomes MA, Brandão AA, Feitosa AD, et al. Brazilian guidelines of hypertension - 2020. Arq Bras Cardiol. 2021;116:516–658.

    Article  PubMed  Google Scholar 

  10. Tay JC, Sule AA, Chew EK, Tey JS, Lau T, Lee S, et al. Ministry of Health clinical practice guidelines: hypertension. Singap Med J. 2018;59:17–27.

    Article  Google Scholar 

  11. Park S, Buranakitjaroen P, Chen CH, Chia YC, Divinagracia R, Hoshide S, et al. Expert panel consensus recommendations for home blood pressure monitoring in Asia: the Hope Asia network. J Hum Hypertens. 2018;32:249–58.

    Article  PubMed  Google Scholar 

  12. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. 2018;138:e426–83.

    PubMed  Google Scholar 

  13. Hiremath S, Sapir-Pichhadze R, Nakhla M, Gabor JY, Khan NA, Kuyper LM, et al. Hypertension Canada’s 2020 evidence review and guidelines for the management of resistant hypertension. Can J Cardiol. 2020;36:625–34.

    Article  PubMed  Google Scholar 

  14. Stergiou GS, Palatini P, Parati G, O’Brien E, Januszewicz A, Lurbe E, et al. 2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 2021;39:1293–302.

    Article  CAS  PubMed  Google Scholar 

  15. Kario K, Shimada K, Pickering TG. Abnormal nocturnal blood pressure falls in elderly hypertension: clinical significance and determinants. J Cardiovasc Pharmacol. 2003;41(Suppl 1):S61–6.

    CAS  PubMed  Google Scholar 

  16. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107:1401–6.

    Article  PubMed  Google Scholar 

  17. Björklund K, Lind L, Zethelius B, Berglund L, Lithell H. Prognostic significance of 24-h ambulatory blood pressure characteristics for cardiovascular morbidity in a population of elderly men. J Hypertens. 2004;22:1691–7.

    Article  PubMed  Google Scholar 

  18. Ungar A, Pepe G, Lambertucci L, Fedeli A, Monami M, Mannucci E, et al. Low diastolic ambulatory blood pressure is associated with greater all-cause mortality in older patients with hypertension. J Am Geriatr Soc. 2009;57:291–6.

    Article  PubMed  Google Scholar 

  19. Fagard RH, Van Den Broeke C, De Cort P. Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens. 2005;19:801–7.

    Article  CAS  PubMed  Google Scholar 

  20. Palmas W, Pickering TG, Teresi J, Schwartz JE, Moran A, Weinstock RS, et al. Ambulatory blood pressure monitoring and all-cause mortality in elderly people with diabetes mellitus. Hypertension. 2009;53:120–7.

    Article  CAS  PubMed  Google Scholar 

  21. Gijón-Conde T, Gorostidi M, Banegas JR, de la Sierra A, Segura J, Vinyoles E, et al. Position statement on ambulatory blood pressure monitoring (ABPM) by the Spanish Society of Hypertension (2019). Hipertens Riesgo Vasc. 2019;36:199–212.

    Article  PubMed  Google Scholar 

  22. Lee JH, Kim KI, Cho MC. Current status and therapeutic considerations of hypertension in the elderly. Korean J Intern Med. 2019;34:687–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Thijs L, Den Hond E, Nawrot T, Staessen JA. Prevalence, pathophysiology and treatment of isolated systolic hypertension in the elderly. Expert Rev Cardiovasc Ther. 2004;2:761–9.

    Article  PubMed  Google Scholar 

  24. Benetos A, Thomas F, Joly L, Blacher J, Pannier B, Labat C, et al. Pulse pressure amplification a mechanical biomarker of cardiovascular risk. J Am Coll Cardiol. 2010;55:1032–7.

    Article  PubMed  Google Scholar 

  25. Winston GJ, Palmas W, Lima J, Polak JF, Bertoni AG, Burke G, et al. Pulse pressure and subclinical cardiovascular disease in the multi-ethnic study of atherosclerosis. Am J Hypertens. 2013;26:636–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Fukutomi M, Kario K. Aging and hypertension. Expert Rev Cardiovasc Ther. 2010;8:1531–9.

    Article  PubMed  Google Scholar 

  27. Bulpitt CJ, Beckett N, Peters R, Staessen JA, Wang JG, Comsa M, et al. Does white coat hypertension require treatment over age 80? Results of the hypertension in the very elderly trial ambulatory blood pressure side project. Hypertension. 2013;61:89–94.

    Article  CAS  PubMed  Google Scholar 

  28. Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension. 2001;38:852–7.

    Article  CAS  PubMed  Google Scholar 

  29. Blauth FG, Vilar LA, Pontes VC, Moriguti JC, Ferriolli E, Lima NK. The effect of frailty on the 24-hour blood pressure pattern in the very elderly. J Clin Hypertens (Greenwich). 2022;24:67–73.

    Article  Google Scholar 

  30. Mokwatsi GG, Hoshide S, Kanegae H, Fujiwara T, Negishi K, Schutte AE, et al. Direct comparison of home versus ambulatory defined nocturnal hypertension for predicting cardiovascular events: the Japan morning surge-home blood pressure (J-HOP) study. Hypertension. 2020;76:554–61.

    Article  CAS  PubMed  Google Scholar 

  31. Pierdomenico SD, Pierdomenico AM, Coccina F, Lapenna D, Porreca E. Circadian blood pressure changes and cardiovascular risk in elderly-treated hypertensive patients. Hypertens Res. 2016;39:805–11.

    Article  PubMed  Google Scholar 

  32. Zhu QO, Tan CS, Tan HL, Wong RG, Joshi CS, Cuttilan RA, et al. Orthostatic hypotension: prevalence and associated risk factors among the ambulatory elderly in an Asian population. Singap Med J. 2016;57:444–51.

    Article  Google Scholar 

  33. Tran J, Hillebrand SL, Meskers CG, Iseli RK, Maier AB. Prevalence of initial orthostatic hypotension in older adults: a systematic review and meta-analysis. Age Ageing. 2021;50:1520–8.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Ghazi L, Drawz PE, Pajewski NM, Juraschek SP. The association of orthostatic hypotension with ambulatory blood pressure phenotypes in SPRINT. Am J Hypertens. 2021;34:511–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Vallelonga F, Romagnolo A, Merola A, Sobrero G, Di Stefano C, Milazzo V, et al. Detection of orthostatic hypotension with ambulatory blood pressure monitoring in parkinson's disease. Hypertens Res. 2019;42:1552–60.

    Article  PubMed  Google Scholar 

  36. Camafort M, Redón J, Pyun WB, Coca A. Intensive blood pressure lowering: a practical review. Clin Hypertens. 2020;26:21.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Zhu Y, Chen X, Geng S, Li Q, Yuan H, Zhou X, et al. Association between ambulatory blood pressure variability and frailty among older hypertensive patients. J Clin Hypertens (Greenwich). 2020;22:1703–12.

    Article  Google Scholar 

  38. Mogi M. Could Management of Blood Pressure Prevent Dementia in the elderly? Clin Hypertens. 2019;25:27.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Kim Y, Lim JS, Oh MS, Yu KH, Lee JS, Park JH, et al. Blood pressure variability is related to faster cognitive decline in ischemic stroke patients: PICASSO subanalysis. Sci Rep. 2021;11:5049.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Xing Y, Sun Y, Wang S, Feng F, Zhang D, Li H. Nocturnal blood pressure rise as a predictor of cognitive impairment among the elderly: a retrospective cohort study. BMC Geriatr. 2021;21:462.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Li CL, Liu R, Wang JR, Yang J. Relationship between blood pressure variability and target organ damage in elderly patients. Eur Rev Med Pharmacol Sci. 2017;21:5451–5.

    PubMed  Google Scholar 

  42. Oh GC, Cho HJ. Blood pressure and heart failure. Clin Hypertens. 2020;26:1.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Kario K, Hoshide S, Mizuno H, Kabutoya T, Nishizawa M, Yoshida T, et al. Nighttime blood pressure phenotype and cardiovascular prognosis: practitioner based nationwide JAMP study. Circulation. 2020;142:1810–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Ueda T, Kawakami R, Nakada Y, Nakano T, Nakagawa H, Matsui M, et al. Differences in blood pressure riser pattern in patients with acute heart failure with reduced mid-range and preserved ejection fraction. ESC Heart Fail. 2019;6:1057–67.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Komori T, Eguchi K, Saito T, Hoshide S, Kario K. Riser pattern is a novel predictor of adverse events in heart failure patients with preserved ejection fraction. Circ J. 2017;81:220–6.

    Article  CAS  PubMed  Google Scholar 

  46. Camafort M, Jhund PS, Formiga F, Castro-Salomó A, Arévalo-Lorido JC, Sobrino-Martínez J, et al. Prognostic value of ambulatory blood pressure values in elderly patients with heart failure: results of the DICUMAP study. Rev Clin Esp (Barc). 2021;221:433–40.

    Article  CAS  Google Scholar 

  47. Camafort-Babkowski M, Adeseye A, Coca A, Damasceno A, De Simone G, Dorobantu M, et al. The global ambulatory blood pressure monitoring (ABPM) in heart failure with preserved ejection fraction (HFpEF) registry: rationale, design and objectives. J Hum Hypertens. 2021;35:1029–37.

    Article  PubMed  Google Scholar 

  48. White WB, Wakefield DB, Moscufo N, Guttmann CR, Kaplan RF, Bohannon RW, et al. Effects of intensive versus standard ambulatory blood pressure control on cerebrovascular outcomes in older people (INFINITY). Circulation. 2019;140:1626–35.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Webb AJ, Mazzucco S, Li L, Rothwell PM. Prognostic significance of blood pressure variability on beat-to-beat monitoring after transient ischemic attack and stroke. Stroke. 2018;49:62–7.

    Article  PubMed  Google Scholar 

  50. Drawz PE, Pajewski NM, Bates JT, Bello NA, Cushman WC, Dwyer JP, et al. Effect of intensive versus standard clinic-based hypertension management on ambulatory blood pressure: results from the SPRINT (systolic blood pressure intervention trial) ambulatory blood pressure study. Hypertension. 2017;69:42–50.

    Article  CAS  PubMed  Google Scholar 

Download references


We want to acknowledge the Korean Society of Hypertension, for its support and help for this review.



Author information

Authors and Affiliations



Conceptualization, MC, JHS. Data curation: MC. Formal Analysis: MC; JHS. Methodology: MC, WJC, JHS. Project administration: MC. Supervision: MC. Visualization: MC. Writing – original draft: MC, WJC, JHS. Writing – review & editing: MC, WJC, JHS. The author(s) read and approved the final manuscript.

Corresponding author

Correspondence to Miguel Camafort.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Camafort, M., Chung, WJ. & Shin, JH. Role of ambulatory blood pressure monitoring in elderly hypertensive patients. Clin Hypertens 28, 22 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: